Search Results - Mukta Arora

Refine Results
  1. 1
    Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning

    Graft-versus-Host Disease Induced Graft-versus-Leukemia Effect: Greater Impact on Relapse and Disease-Free Survival after Reduced Intensity Conditioning by Daniel J. Weisdorf, Mei-Jie Zhang, Mukta Arora, Mary M. Horowitz, J. Douglas Rizzo, Mary Eapen

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Corticosteroid Dose as a Risk Factor for Avascular Necrosis of the Bone after Hematopoietic Cell Transplantation

    Corticosteroid Dose as a Risk Factor for Avascular Necrosis of the Bone after Hematopoietic Cell Transplantation by Sarah McAvoy, K. Scott Baker, Daniel Mulrooney, Anne Blaes, Mukta Arora, Linda J. Burns, Navneet S. Majhail

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Chronic graft-versus-host disease: A prospective cohort study

    Chronic graft-versus-host disease: A prospective cohort study by Mukta Arora, Linda J. Burns, Stella M. Davies, Margaret L. MacMillan, Todd E. DeFor, Wesley J. Miller, Daniel J. Weisdorf

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Relapse and Late Mortality in 5-Year Survivors of Myeloablative Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia in First Chronic Phase

    Relapse and Late Mortality in 5-Year Survivors of Myeloablative Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia in First Chronic Phase by John M. Goldman, Navneet S. Majhail, John P. Klein, Zhiwei Wang, Kathleen A. Sobocinski, Mukta Arora, Mary M. Horowitz, J. Douglas Rizzo

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia

    Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia by Sergio Giralt, Mukta Arora, John M. Goldman, Stephanie J. Lee, Richard T. Maziarz, Philip L. McCarthy, Kathleen A. Sobocinski, Mary M. Horowitz

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

    Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease by Mukta Arora, John E. Wagner, Stella M. Davies, Bruce R. Blazar, Todd E. DeFor, H Enright, Wesley J. Miller, Daniel J. Weisdorf

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

    Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation by Shernan G. Holtan, Todd E. DeFor, Aleksandr Lazaryan, Nelli Bejanyan, Mukta Arora, Claudio G. Brunstein, Bruce R. Blazar, Margaret L. MacMillan, Daniel J. Weisdorf

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical Cord Blood and Matched Related Donor Transplants

    Does the Hematopoietic Cell Transplantation Specific Comorbidity Index Predict Transplant Outcomes? A Validation Study in a Large Cohort of Umbilical Cord Blood and Matched Related... by Navneet S. Majhail, Claudio G. Brunstein, Sarah McAvoy, Todd E. DeFor, Ahmed Al-Hazzouri, D.C. Setubal, Mukta Arora, Chap T. Le, John E. Wagner, Daniel J. Weisdorf

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study

    Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study by Christopher Fraser, Ravi Bhatia, Kirsten K. Ness, Andrea Carter, Liton Francisco, Mukta Arora, Pablo Parker, Stephen J. Forman, Daniel J. Weisdorf, James G. Gurney, K. Scott Baker

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors

    Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors by Aleksandr Lazaryan, Daniel J. Weisdorf, Todd E. DeFor, Claudio G. Brunstein, Margaret L. MacMillan, Nelli Bejanyan, Shernan G. Holtan, Bruce R. Blazar, John E. Wagner, Mukta Arora

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease

    Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease by Jeanne Palmer, Xiaoyu Chai, Joseph Pidala, Yoshihiro Inamoto, Paul J. Martin, Barry E. Storer, Iskra Pusic, Mary E.D. Flowers, Mukta Arora, Steven Z. Pavletic, Stephanie J. Lee

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease

    Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease by Areej El‐Jawahri, Joseph Pidala, Nandita Khera, William A. Wood, Mukta Arora, Paul A. Carpenter, Jeanne Palmer, Mary E.D. Flowers, Madan Jagasia, Yi‐Bin Chen, Stephanie J. Lee

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

    An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease by Paul J. Martin, Barry E. Storer, Yoshihiro Inamoto, Mary E.D. Flowers, Paul A. Carpenter, Joseph Pidala, Jeanne Palmer, Mukta Arora, Madan Jagasia, Sally Arai, Corey Cutler, Stephanie J. Lee

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation

    High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation by Navneet S. Majhail, Mary E.D. Flowers, Kirsten K. Ness, Madan Jagasia, Paul A. Carpenter, Mukta Arora, Sally Arai, Laura Johnston, Paul J. Martin, K. Scott Baker, S J Lee, Linda J. Burns

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Reduced-Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor

    Reduced-Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor by Navneet S. Majhail, Claudio G. Brunstein, Marcie Tomblyn, Avis J. Thomas, Jeffrey S. Miller, Mukta Arora, Dan S. Kaufman, Linda J. Burns, Arne Slungaard, Philip B. McGlave, John E. Wagner, Daniel J. Weisdorf

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma

    Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma by Navneet S. Majhail, Daniel J. Weisdorf, Todd E. DeFor, Jeffrey S. Miller, Philip B. McGlave, Arne Slungaard, Mukta Arora, Norma K.C. Ramsay, Paul J. Orchard, Margaret L. MacMillan, Linda J. Burns

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Hospitalization rates among survivors of childhood cancer in the childhood cancer survivor study cohort

    Hospitalization rates among survivors of childhood cancer in the childhood cancer survivor study cohort by Beth A. Kurt, Val Nolan, Kirsten K. Ness, Joseph P. Neglia, Jean M. Tersak, Melissa M. Hudson, Gregory T. Armstrong, Raymond J. Hutchinson, Wendy M. Leisenring, Kevin C. Oeffinger, Leslie L. Robison, Mukta Arora

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Machine learning reveals chronic graft-<i>versus</i>-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies

    Machine learning reveals chronic graft-<i>versus</i>-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies by Jocelyn S. Gandelman, Michael Byrne, Akshitkumar M. Mistry, Hannah G. Polikowsky, Kirsten E. Diggins, Heidi Chen, Stephanie J. Lee, Mukta Arora, Corey Cutler, Mary E.D. Flowers, Joseph Pidala, Jonathan M. Irish, Madan Jagasia

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study

    Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study by Edmund K. Waller, David B. Miklos, Corey Cutler, Mukta Arora, Madan Jagasia, Iskra Pusic, Mary E.D. Flowers, Aaron C. Logan, Ryotaro Nakamura, Stephen Chang, Fong Clow, Indu Lal, Lori Styles, Samantha Jaglowski

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients

    Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients by Mukta Arora, Can-Lan Sun, Kirsten K. Ness, Jennifer Berano Teh, Jessica Wu, Liton Francisco, Saro H. Armenian, Amy Schad, Golnaz Namdar, Alysia Bosworth, Linus Kuo, Daniel J. Weisdorf, Stephen J. Forman, Smita Bhatia

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: